Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Drug Combo Blocks HIV Infection in Mice

Truvada might someday prevent virus in people, researchers say

By Randy Dotinga
HealthDay Reporter


Related Encyclopedia
 border=
Abscess
Actinomycosis
Acute Myeloid Leukemia (Adult)
AIDS and HIV Infection
More...

Related Healthscout Videos
 border=
Laser Surgery Saves Twins
Attacking Implant Infections
How Do I Adhere to My HIV Medications?
How Do I Use a Male and Female Condom?
More...

Related Animations
 border=
Erectile Dysfunction
Menopause
More...

Related Drug Information
 border=
Abilify
Augmentin
Bactroban Cream
Bactroban Ointment
More...

Related News Articles
 border=
Problem Drinkers Marry Later, Break Up Sooner: Study
Genetics Could Play Role in Teen Drinking
Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical
Friends a Big Influence on Grades in Middle School: Study
More...

FRIDAY, Jan. 22 (HealthDay News) -- New research in mice suggests that a commonly used drug combination might protect people from being infected by the AIDS virus through the major routes of transmission.

Previous research showed that the drugs could prevent vaginal transmission. In this study, the medication prevented HIV infection through anal sex and intravenously.

Text Continues Below



The research raises the prospect that "one single pill once a day, totally available in the pharmacy for patients, can be used to prevent transmission by any mode anywhere in the world," said J. Victor Garcia-Martinez, a professor of medicine at the University of North Carolina at Chapel Hill and senior author of a study published online Jan. 20 in PloS One.

But there's no guarantee that the drugs will protect people, even though the mice had "humanized" immune systems. And the idea of preventing HIV transmission through medication raises a host of issues.

The drug in question, Truvada, is a combination of the medications tenofovir and emtricitabine. It's used to treat people with AIDS and to stop HIV infection from setting in after exposure to the virus. In hospitals, doctors and nurses sometimes take it after getting stuck with a needle that might be contaminated.

Garcia-Martinez and his colleagues previously found that the drug prevented vaginal transmission of HIV in mice. In the new study, they examined mice known as "BLT" because human bone marrow, liver and thymus cells had been transplanted into their bodies, giving them what the researchers consider to be a human immune system.

Some mice got doses of Truvada and others did not; all were exposed to HIV rectally or intravenously at a higher level than typical in human exposure. Of the 17 mice given Truvada, only one -- which had been exposed intravenously -- became infected.

Page:  1 | 2 | Next >>

Copyright © 2010 HealthDay. All rights reserved.
Last updated 1/22/2010

Related Links
 border=
From Healthscout's partner site on genital herpes, HerpesConnection.com
Learn about genital herpes symptoms
What are herpes treatment options?
Get the details about herpes simplex 1 and 2.




SOURCES: J. Victor Garcia-Martinez, Ph.D., professor, medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, N.C.; A. David Paltiel, Ph.D., professor, public health, and acting head, division of health policy and administration, Yale School of Medicine, New Haven, Conn.; Jan. 21, 2010, PloS One, online


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2011. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire